The ANGEL-MS application is only open to the participants of the GNC-004 clinical study.
How it works:
-You will be provided an activity bracelet (Garmin vívofit 3) that connects directly with the application;
-The bracelet will automatically synchronize with the app if you leave it running in background mode; otherwise you will need to manually sync (by holding the button on the bracelet);
-The app will prompt you to respond to a daily/weekly questionnaire at 7pm via notifications. You will have 6 hours to respond to the questionnaire from 7pm to 1am;
-In the application a “synchronization graph” will show if you have filled in the questionnaires and synchronized your steps over the last 28 days;
-The activity data and questionnaire responses are anonymized and stored on a Tactio secured cloud.
Who is eligible to participate to Angel-MS?
-Participants of the GNC-004 clinical study who fill specific selection/inclusion criteria. Ask your investigator if you are eligible.
Who is running the study?
-GeNeuro; a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases, including multiple sclerosis (MS).
Who developed this app?
-Tactio Health Group; a digital health solutions provider helping provider, payer, pharma and research companies make the patient experience digital, mobile & connected.